Literature DB >> 20054702

A case with coincidental diagnosis of primary central nervous system lymphoma and lymph node sarcoidosis.

Eva J Greiner1, Lars-Olof Mügge, Bernd F M Romeike, Theodoros Topalidis, Bernhard Theis, Andreas Ragoschke-Schumm, Otto W Witte, Albrecht Günther.   

Abstract

Primary central nervous system lymphoma (PCNSL) is rare. Clinical and histological differential diagnosis of systemic lymphoma and sarcoidosis continues to be a challenge. The first case report in the German and English literature of PCNSL and synchronous sarcoidosis is presented. Synchronous mediastinal lymphadenopathy suggestive of non-Hodgkin's lymphoma (NHL) or sarcoidosis was noted. Both conditions require alternative therapeutic and prognostic considerations to PCNSL. A regime of intrathecal and adjuvant systemic chemotherapy led to transient clinical improvement prior to the patient's demise through overwhelming sepsis and multiorgan failure. Post mortem findings confirmed synchronous PCNSL with mediastinal lymph node sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054702     DOI: 10.1007/s11060-009-0101-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden.

Authors:  J Ji; X Shu; X Li; K Sundquist; J Sundquist; K Hemminki
Journal:  Ann Oncol       Date:  2009-02-11       Impact factor: 32.976

Review 2.  Granulomatous reactions cause symptoms or clinically imitate treatment resistance in small lymphocytic lymphoma/chronic lymphocytic leukaemia more frequently than in other non-Hodgkin lymphomas.

Authors:  A Brunner; J Kantner; A Tzankov
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

3.  Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy.

Authors:  R C Young; D M Howser; T Anderson; R I Fisher; E Jaffe; V T DeVita
Journal:  Am J Med       Date:  1979-03       Impact factor: 4.965

4.  The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis.

Authors:  Janet E Olson; Carol A Janney; Ravi D Rao; James R Cerhan; Paul J Kurtin; David Schiff; Richard S Kaplan; Brian Patrick O'Neill
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

5.  Acute myeloblastic leukemia and sarcoidosis. Implications for pathogenesis.

Authors:  J M Reich
Journal:  Cancer       Date:  1985-01-15       Impact factor: 6.860

6.  [The "sarcoidosis-lymphoma syndrome"--a lymphocyte dysregulation?].

Authors:  H S Linnenberg; T C Medici; K Rhyner
Journal:  Pneumologie       Date:  1992-06

7.  Neurosarcoidosis.

Authors:  Ashok V Patel; David E Stickler; William R Tyor
Journal:  Curr Treat Options Neurol       Date:  2007-05       Impact factor: 3.598

8.  CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003.

Authors:  I S Haldorsen; J Kråkenes; B K Krossnes; O Mella; A Espeland
Journal:  AJNR Am J Neuroradiol       Date:  2009-01-22       Impact factor: 3.825

Review 9.  Sarcoidosis.

Authors:  Hilario Nunes; Diane Bouvry; Paul Soler; Dominique Valeyre
Journal:  Orphanet J Rare Dis       Date:  2007-11-19       Impact factor: 4.123

10.  The incidence of malignant tumours in patients with respiratory sarcoidosis.

Authors:  H Brincker; E Wilbek
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.